How to improve the survival of patients with rectal cancer?

Rectal cancer is a common malignant tumor in the gastrointestinal tract. Its incidence rate is second only to stomach and esophageal cancer. It is the most common part of colorectal cancer (accounting for about 65%). The vast majority of genetic patients are over 40 years old, and those under 30 years old account for about 15%. It is more common in men, and the ratio of men to women is 2-3:1. Rectal cancer is a lifestyle disease. At present, it has jumped to the second place in the cancer rankings, so diet and lifestyle are the root causes of cancer. Due to the similarities in causes and symptoms, rectal cancer is often mentioned together with colon cancer. Rectal cancer patients need to receive correct treatment in time to improve their quality of life and survival period. So how should we improve the survival period of rectal cancer patients? In order to improve the survival rate of patients with advanced rectal cancer, we need to focus on the following aspects:

1. First check the extent of the disease

First, various examination methods are used to clarify the cause and severity of the disease. For example, a colonoscopy is used to examine the entire intestine to determine whether the lesion is benign or malignant. If rectal cancer has been confirmed, ultrasound, CT, PET/CT should be performed to understand the extent of the tumor development, whether there is liver metastasis, lymph node metastasis, etc., so as to formulate a suitable treatment plan;

2. Radiotherapy before tumor removal

After a clear diagnosis, the tumor should not be removed immediately. Instead, radiotherapy should be performed for 10 days before surgery and then rest for 2 to 3 weeks to maximize the effect of radiotherapy. Neoadjuvant radiotherapy before rectal cancer surgery is to use radiation to kill tumor cells, shrink the tumor, and eliminate micro-metastases around the tumor to increase the surgical resection rate.

The full name of the operation is total mesorectal excision, which is performed through laparoscopy or open surgery. Compared with traditional rectal cancer surgery, it has less bleeding and more thorough resection, and can effectively reduce the local recurrence rate.

Some patients may need adjuvant chemotherapy after surgery, but not all patients need chemotherapy. It depends on the surgical situation, the severity of the patient's disease, and the patient's physical condition. Chemotherapy will last for 3 to 6 months to further kill possible micro-metastatic lesions and improve the cure rate;

3. Check frequently after treatment

The third level is regular follow-up after treatment. Even if all visible tumors are removed during surgery, tumor cells may still appear in other parts of the body. Most tumor recurrences will be detected within two years after surgery, so follow-up during this period is the most frequent.

Of course, after rectal cancer patients have undergone surgery and chemotherapy, in order to prevent further metastasis and recurrence of the disease, they need to use other methods for adjuvant treatment. They can choose biological treatment to prolong survival and improve quality of life. The specific methods are as follows:

Entering the 21st century, facing the huge risks and toxic side effects of surgery and chemotherapy, we can use the "DC+CIK biotherapy" technology for adjuvant treatment. By collecting the patient's blood mononuclear cells for proliferation and culture, we can obtain mature DC cells with tumor cell recognition ability and more, more active and lethal CIK cells, and then infuse these two cells back into the patient's body twice to use them to specifically kill tumor cells. It is safe and has no toxic side effects, activates the human immune mechanism, improves the human immune ability, and effectively removes the remaining tumor cells and metastatic micro-lesions in the patient's body, so as to control tumor growth, prevent tumor recurrence, metastasis and deterioration, and achieve multiple goals of extending the patient's survival and rapidly improving the patient's quality of life. Since biotherapy technology uses the body's own immune cells instead of traditional chemical drugs to kill tumor cells, it is safe and has no toxic side effects. The majority of cancer patients can use it with confidence, especially to assist in the surgical treatment of early gastric cancer patients, which can achieve significant therapeutic effects and can completely achieve the purpose of extending the patient's survival and rapidly improving the patient's quality of life.

The above is how to improve the survival of patients with rectal cancer. Expert Tips: If your health shows symptoms of the disease, you can choose the appropriate treatment according to your symptoms, but do not delay the diagnosis, and do not let your life be ruined in hesitation. You should go to a regular hospital for treatment in time to avoid delaying the disease and causing serious consequences. If you have other questions, please consult our online experts or call for consultation. Believe in miracles, I wish you health, happiness, and joy!

Rectal cancer http://www..com.cn/zhongliu/zca/